Navigation Links
External CounterPulsation (ECP) Centers

ProductsExternal CounterPulsation (ECP) Centers
Company MedCath Corporation
Item External CounterPulsation (ECP) Centers
Features ECP Clinical Benefits

Clinical studies have shown that ECP treatment produces improved perfusion of the ischemic myocardium in patients with coronary artery disease. The following patient benefits have been observed:

  • Relief of anginal symptoms
  • Resolution of reversible ischemic defects found upon radio nuclide assessment
  • Improved exercise treadmill times
  • Rectification of exercise ECG ST segment abnormalities
  • No need or reduction of need for anti-anginal medication
  • Improved ability to perform normal activities of daily living
The ACC and Mayo Clinic recently recommended ECP for certain angina patients.
Description Looking for a way to help your patients with chronic angina or end stage cardiovascular disease? Based on the outcomes of several thousand cardiac patients nationwide, External Counterpulsation (ECP) has improved the quality of their lives; it has allowed many to perform normal activities of daily living.

MedCath Diagnostics, LLC, a national provider of cardiac diagnostic services, has assisted physicians with placing this proven cardiac treatment therapy within their office and/or diagnostic centers. We will help with the upfront investment needed to purchase equipment and our development staff will establish a turnkey facility that leaves you free to care for your patients.

Description of Therapy

Patients lie on a bed wearing a series of compressive air cuffs (resembling Blood Pressure cuffs) that are wrapped around the patients legs. The vascular networks in the large muscles of patients legs are compressed in sequence, progressing from the calves upward. Each wave of pressure is electronically synchronized with the patients heartbeat via a microprocessor-interpreted ECG signal, so that the increased blood flow is delivered to the heart at the precise moment of diastole. The result is much higher coronary flow and perfusion as well as increased venous return. Recent studies suggest that ECP promulgates the development of new collaterals to ischemic regions of the myocardium through angiogenesis.

Treatment Course

The recommended regimen is once daily, one-hour treatment, five (5) days a week for seven (7) weeks. Twice daily treatments are an option for some patients, to reduce treatment course duration.

Medicare covers ECP and the reimbursement rates have steadily risen over the past several years. Reimbursement rates for 2003 increased eleven (11) percent from 2000 rates. ECP centers across the country report reimbursement successes with nearly all third party reimbursement payors.

Info MedCath Corporation
Customer Service: (704) 708-6600
Web site: http://www.medcath.com

Related medicine products :

1. The External Neurological Drainage System
2. Monitorr ICP External CSF Drainage and Monitoring System
3. Monitorr ICP External CSF Drainage System
4. EDS 3 CSF External Drainage System
5. Lumbar External Drainage System (LED)
6. External Ventricular Drainage (EVD)
7. Becker External Drainage and Monitoring System
8. Dual-Chamber Model 5388 External (Temporary) Pulse Generator
9. Single-Chamber Model 5348 External (Temporary) Pulse Generator
10. The Hoffmann® II For External Fixation
11. XCaliber External Fixator
... Drawing on over 20 years of ... AquilionTM 16 is at the forefront of ... ability to acquire volumetric data at high ... was created based on extensive clinical experience ...
... IDT 16 is Philips premium 16-slice CT scanner. ... performed to automatically delivering high quality, advanced results, ... in a platform that has been the most ... do comprehensive organ assessment literally within seconds, and ...
... Instruments are designed to facilitate disc removal, ... graft during interbody fusion. The TLIF instruments ... use during TLIF, for which they were ... used very effectively in PLIF and ALIF. ...
... insertion assembly incorporates slotted guides for ... The PathFinder MIS System uses an ... screw insertion assembly incorporates crescent-shaped slotted ... evolutionary Pathfinder MIS pedicle screw system ...
Medicine Products:
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... users to clarify, edit and delete any message including ones already sent. , While ...
(Date:7/31/2015)... ... , ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened ... 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and ... Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... new store run by GoodThreads. The store can be accessed by visiting ... many of which are customizable. The best part: whenever a product is purchased, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and blogs ... social media profiles to better connect with the public. The agency website at ... share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article ... see if they could reach a consensus on the steps that need to be ... the group reached 90 percent consensus on a series of steps that each surgeon ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... , THURSDAY, May 3 (HealthDay News) -- A ... with schizophrenia, cutting patients, risk of relapse by 60 percent. ... also found that schizophrenia patients who take antipsychotics are much ... and have a better quality of life than patients who ...
... jogging increases the life expectancy of men by 6.2 years ... the Copenhagen City Heart study presented at the EuroPRevent2012 meeting. ... hazardous, Peter Schnohr told delegates that the study,s most recent ... hours of jogging per week at a "slow or ...
... eating is motivated by pleasure, rather than hunger, endogenous rewarding ... to a recent study accepted for publication in The Endocrine ... The phenomenon ultimately affects body mass and may be a ... refers to the desire to eat for pleasure, and to ...
... New York, NYThe United States spends more on health care ... superior" care, according to a new study from The Commonwealth ... on health care services, while other countries in the study ... and Switzerland) as much. While the U.S. performs well on ...
... 2D mammography screening results in a 40% reduction in ... a new study shows., The study, conducted at Yale ... 7,578 screening mammograms, found that the recall rate was ... It was 11.1% for 2D screening mammography alone, ...
... with benign breast biopsies do not need follow-up at six months; ... shows. , The study, conducted at Moffitt ... and 24 months. No cancer was found in these patients ... the authors of the study. "Of the 197 follow-up examinations ...
Cached Medicine News:Health News:Antipsychotics Do Help Many With Schizophrenia, Study Finds 2Health News:Antipsychotics Do Help Many With Schizophrenia, Study Finds 3Health News:Regular jogging shows dramatic increase in life expectancy 2Health News:Regular jogging shows dramatic increase in life expectancy 3Health News:Pleasure eating triggers body's reward system and may stimulate overeating 2Health News:US spends far more for health care than 12 industrialized nations, but quality varies 2Health News:US spends far more for health care than 12 industrialized nations, but quality varies 3Health News:US spends far more for health care than 12 industrialized nations, but quality varies 4Health News:Digital breast tomosynthesis cuts recall rates by 40 percent 2
(Date:7/31/2015)... , July 31, 2015 Quietly, ... of experience, the domestic pharmaceutical industry is strong, with ... products to high international standards. One place ... is in sub-Saharan Africa: Morocco has quietly become the ... South Africa . Indeed, Moroccan pharma companies ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 /PRNewswire/ ... Co., Ltd. (Headquarters: Tokyo , President ... Therapeutics, Inc. (Headquarters: San Diego, California ... "NASDAQ: HALO") have signed a clinical collaboration agreement to ... "eribulin") in combination with Halozyme,s investigational drug PEGPH20 (PEGylated ...
(Date:7/31/2015)... Magnaquest, a leading Subscription ... cloud computing operators has signed a Proof of ... Internet of Things (IoT) related initiative. The PoC ... model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ) ... business innovations to make healthcare services more accessible ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2